Search forAll
Found 26,477 results
This company is set to soar as the uranium supply deficits expand.
We called in an expert to give us the full scoop on this opportunity.
It’s time to move at AI speed in the biotech industry.
Soaring capex spending is bullish for AI.
It's not gold or silver. So, you haven't missed the buy zone.
It is already outperforming the market by a lot. And it still has room to run high.
This company is leading the charge on faster, more powerful communications.
And it’s something nobody is talking about.
Investors may need to get nimble, but opportunity persists in this market.
Here are 3 other dates that set up this new catalyst.